Vaccine Scheduler
Herpes Zoster: Recommended vaccinations
| General recommendation | |
| Recommendation for specific groups only | |
| Catch-up (e.g. if previous doses missed) | |
| Vaccination not funded by the National Health system | |
| Mandatory vaccination |
| Years | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 18 | 26 | 50 | 59 | 60 | 64 | 65 | 74 | 75 | ≥ 76 | |
| Austria | ZOS1 | ZOS1 | ||||||||
| Belgium | ZOS2 | |||||||||
| Bulgaria | ||||||||||
| Croatia | ZOS3 | |||||||||
| Cyprus | ZOS4 | |||||||||
| Czechia | ZOS5 | ZOS | ||||||||
| Denmark | ||||||||||
| Estonia | ||||||||||
| Finland | ||||||||||
| France | ZOS6 | ZOS6 | ||||||||
| Germany | ZOS7 | ZOS7 | ||||||||
| Greece | ZOS8 | ZOS9 | ||||||||
| Hungary | ||||||||||
| Iceland | ||||||||||
| Ireland | ||||||||||
| Italy | ZOS10 | |||||||||
| Latvia | ||||||||||
| Liechtenstein | ZOS | |||||||||
| Lithuania | ||||||||||
| Luxembourg | ZOS11 | ZOS12 | ||||||||
| Malta | ||||||||||
| Netherlands | ||||||||||
| Norway | ||||||||||
| Poland | ||||||||||
| Portugal | ||||||||||
| Romania | ||||||||||
| Slovakia | ||||||||||
| Slovenia | ||||||||||
| Spain | ZOS13 | ZOS14 | ||||||||
| Sweden | ||||||||||
Footnotes:
- Zoster vaccination refunded for certain high-risk individuals aged 18 and over. Free of charge for people aged 60 and over.
- Partially funded only for some risk groups. https://www.health.belgium.be/sites/default/files/uploads/fields/fpshealth_theme_file/20220906_css-9684_herpes_zoster_vweb.pdf
- Vaccination is recommended and funded by Croatian Health Insurance for certain at risk groups 18+ (eg people after HSCT, people on JAK inhibitors therapy).
- May include two doses depending on the vaccine product, in which case are administered two months apart.
- Recommended for adults with certain risk conditions and for all individuals of age 50 and older. Vaccination not funded by the National Health System. More information: https://www.vakcinace.eu/doporuceni-a-stanoviska/doporuceni-ceske-vakcinologicke-spolecnosti-cls-jep-pro-ockovani-proti-pasovemu-oparu-herpes-zoster
- Recommended for adults 18-64 years with certain risk conditions (immunodepressed). Two doses with a minimal interval of 2 months between doses. Vaccination with the inactivated herpes zoster subunit vaccine. for further information, please refert to https://sante.gouv.fr/prevention-en-sante/preserver-sa-sante/vaccination/calendrier-vaccinal
- 2 doses with an interval of 2 to 6 months respectively between doses; for individuals aged 18-59 years only indicated for persons with certain medical condition or underlying disease associated with increased risk of herpes zoster. Vaccination with the inactivated herpes zoster subunit vaccine. See recommendation background paper: https://link.springer.com/article/10.1007/s00103-019-02882-5
- Two doses (RZV vaccine) in immunocompromised.
- RZV 2 doses
- 1 or 2 doses depending on the vaccine used
- for immunosuppressed or ahead of period of immunosuppression. 2 doses 1-2 months apart.
- 2 doses 2-6 months apart
- Recommended for adults with certain risk conditions. Two doses with a minimal interval of 2 months between doses. Vaccination with the inactivated herpes zoster subunit vaccine. Additional information available: https://www.sanidad.gob.es/areas/promocionPrevencion/vacunaciones/programasDeVacunacion/docs/HerpesZoster_RecomendacionesVacunacion.pdf
- Two doses with a minimal interval of 2 months between doses. Vaccination with the inactivated herpes zoster subunit vaccine. Additional information available: https://www.sanidad.gob.es/areas/promocionPrevencion/vacunaciones/programasDeVacunacion/docs/HerpesZoster_RecomendacionesVacunacion.pdf